Which systemic therapy in concurrent chemoradiotherapy?

Date

07 Oct 2016

Session

Optimal treatment of stage III NSCLC

Presenters

Johan Vansteenkiste

Authors

J.F. Vansteenkiste

Author affiliations

  • Respiratory Oncology Unit - Department Respiratory Diseases, University Hospitals KU Leuven, 3000 - Leuven/BE
More

Resources

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings